Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-28

Clinical Trial Update: FET-PET-Guided Management of Pseudoprogression in Glioblastoma [NA]

View source ↗

Summary

A clinical trial studying FET-PET-guided management of pseudoprogression in glioblastoma, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Veerle Ruijters | Conditions: Glioblastoma, Radionecrosis of Brain | NA | Status: NOT_YET_RECRUITING